High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma.
This is a review of data published in the literature on the role of marrow ablative treatment and blood or marrow transplantation for high-grade and intermediate-grade lymphoma. Timing and epidemiology are reviewed before the various clinical situations (primary refractory partial responses, complete responses and relapses). The Lyon consensus conference held in 1998 has also extensively been used and quoted.
Philip
Thierry
T
Bone Marrow Transplant Department, Centre Léon Bérard, 28 rue Laënnec, 69008, Lyon, France. philip@lyon.fnclcc.fr
Biron
Pierre
P
D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D012074:Remission Induction; D015996:Survival Rate; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents